GlassScriptPhysician profile
Tj J Maroon
NPI 1720056153
$597.47
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.86 · 2020: $79.21 · 2021: $113 · 2022: $95.69 · 2023: $138 · 2024: $83.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $73.29 | 2021-2024 | |
| Collegium Pharmaceutical, INC. | $59.62 | 2019-2020 | |
| Grt US Holding, INC. | $52.74 | 2021 | |
| Si-Bone, INC. | $51.31 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.16 | 2019 | |
| Redhill Biopharma INC. | $49.00 | 2020-2022 | |
| Pfizer INC. | $47.11 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.83 | 2022-2024 | Relistor |
| Merz Pharmaceuticals, LLC | $33.25 | 2023 | Xeomin |
| Boston Scientific Corporation | $33.01 | 2022 | |
| Medtronic, INC. | $22.15 | 2023 | Synchromedii |
| Biohaven Pharmaceutical Holding Company LTD. | $20.65 | 2022 | |
| Forte Bio-Pharma LLC | $19.99 | 2021 | |
| Djo, LLC | $19.46 | 2024 | Donjoy |
| Horizon Therapeutics Plc | $17.53 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $13.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tj Maroon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.